14-day Premium Trial Subscription Try For FreeTry Free
BILLERICA, Mass., Aug. 29, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that
Start Time: 08:30 January 1, 0000 8:57 AM ET Conformis, Inc. (NASDAQ:CFMS ) Q2 2022 Earnings Conference Call August 09, 2022, 08:30 AM ET Company Participants Mark Augusti - President and CEO Bob Howe

ConforMIS (CFMS) Reports Q2 Loss, Tops Revenue Estimates

10:05pm, Monday, 08'th Aug 2022 Zacks Investment Research
ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?

Conformis Reports Second Quarter 2022 Financial Results

08:45pm, Monday, 08'th Aug 2022 GlobeNewswire Inc.
BILLERICA, Mass., Aug. 08, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), an orthopedic medical device company that features personalized knee and hip replacement products, announced today
ConforMIS (CFMS) delivered earnings and revenue surprises of -12.50% and 1.09%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Gainers AMTD IDEA Group (NYSE: AMTD) shares jumped 284% to $8.00 after jumping 18% on Monday. The company owns 90%+ of AMTD Digital. Applied DNA Sciences, Inc. (NASDAQ: APDN) gained 166% to $1.8801
Gainers AMTD IDEA Group (NYSE: AMTD) rose 217.3% to $6.60 in pre-market trading after jumping 18% on Monday. The company owns 90%+ of AMTD Digital. Apexigen (NASDAQ: APGN) rose 37.2% to $29.28 in pre
Agreement enables interested Vizient members, including academic medical centers, acute care facilities, and ambulatory surgery centers (ASCs), to purchase Conformis knee and hip replacement solutions
BILLERICA, Mass., July 28, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today th
BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it
BILLERICA, Mass., July 05, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it wi
Gainers Fujian Blue Hat Interactive Entertainment Technology Ltd. (NASDAQ: BHAT) shares jumped 263% to $2.73 on Thursday. Blue Hat Interactive terminated its previously proposed shelf takedown offer
BILLERICA, Mass., May 10, 2022 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today that
Conformis, Inc. (NASDAQ:CFMS ) Q1 2022 Earnings Conference Call May 4, 2022 8:30 AM ET Company Participants Mark Augusti - President and Chief Executive Officer Bob Howe - Chief Financial Officer Conf

ConforMIS (CFMS) Reports Q1 Loss, Tops Revenue Estimates

12:25pm, Wednesday, 04'th May 2022 Zacks Investment Research
ConforMIS (CFMS) delivered earnings and revenue surprises of -28.57% and 11.58%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE